GSM250002[Accession] - GEO DataSets

Warning: The NCBI web site requires JavaScript to function. more...

Format

Summary
Summary (text)
Unique Identifier List

Sort by

Default order
Number of Samples (High to Low)
Number of Samples (Low to High)

Send to:

Choose Destination

File
Clipboard
Collections

Search results

Items: 3

Select item 2000098931.

A gene expression signature predicting the recurrence of tamoxifen-treated primary breast cancer.

(Submitter supplied) A 36-gene classifier was constructed through expression profiling of 132 tumors from tamoxifen-treated patients using 70-mer oligonucleotide microarrays. The robustness of the signature was demonstrated using expression data from 83 independent tumors. The 36-gene signature was (i) more efficient to predict disease-free survival than the traditional histo-pathological prognostic factors, (ii) as effective as the Nottingham Prognostic Index or the "Adjuvant!" software, and (iii) the only independent prognostic factor. more...

Organism:: Homo sapiens

Type:: Expression profiling by array

Platform:: GPL5049
155 Samples

Download data: GPR, TXT

Series

Accession:: GSE9893

ID:: 200009893

PubMed Full text in PMC Similar studies Analyze with GEO2R

Select item 1000050492.

MLRG Human 21K V12.0

(Submitter supplied) The Human Genome Oligo Set Version 2.0 contains 21,329 70mers representing 21,329 genes obtained from the UniGene Database Build Hs 147 and the Human RefSeq Database, both developed and maintained at the National Center of Biotechnology Information (www.ncbi.nlm.nih.gov/UniGene). The set also includes 12 unique positive and 12 unique negative controls provided in 16 replicates in a 384-well plate. Protocol: Manufacturing microarrays The Human Qiagen/Operon Array Ready oligo set Version 2.0 were spotted using the Amersham Biosciences Lucidea Array spotter on aminosilane-coated mirror glass slides (7 Star, Amersham Biosciences). more...